Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control

Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control Referring to Tehran Heart Center Since June 2007 to June 2009

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03338153

Enrollment

1353

Registered

2017-11-09

Start date

2007-10-31

Completion date

2013-03-31

Last updated

2017-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Diabetes

Brief summary

the purpose of this study is to determine whether appropriate control of diabetes around the PCI time is related with MACE and outcome of diabetic patients.

Detailed description

Despite recent advances in coronary revascularization, cardiovascular disease accounts for about 75% of all hospital admissions in diabetic patients.although the introduction of drug-eluting stents has reduced the rates of restenosis after PCI, diabetic patients undergoing PCI will have poorer clinical outcomes.In this study, we sought to investigate whether a pre and post procedural glycemic control in diabetic patients,as reflected by HgbA1C prior,1 and 6 months after elective PCI,was related to major advance cardiac events (MACE) during 3 year follow up.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* age between 18-75 * coronary stenosis \> 70%

Exclusion criteria

* Myocardial infarction in 72 hours prior to PCI * LVEF \< 30% * Residual Stenosis\>30% * Cr level \> 2.0 * hemodynamic compromise during intervention * Left main lesions * PCI for vein grafts

Design outcomes

Primary

Measure	Time frame
Major adverse cardiac event	during 3 years after per-cutaneous coronary intervention

Secondary

Measure	Time frame
target vessel revascularization	during 3 years after PCI
target lesion revascularization	during 3 years after PCI

Countries

Iran

Outcome results